Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FolAMI study of levofolinate in acute myocardial infarction
NL-OMON33443Phase 3Not yet recruiting
- Sponsor
- Maastricht University Medical Center+
- Start
- Jun 2009
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in acute ST-segment elevation myocardial infarction (STEMI) comparing Levofolinate with Placebo (2 arms). Primary endpoints: Improvement of endothelial function and Improvement of myocardial function. Planned start Jun 2009; status: not yet recruiting.
02
Drugs
levoleucovorin
03
Conditions
acute ST-segment elevation myocardial infarction (STEMI)
Beyond the preview
Go deeper on NL-OMON33443.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON33443.